{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:19:34Z","timestamp":1790720374779,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The aim of the study was to increase the uptake of the SSTR2-targeted radioligand Lu-177-DOTATATE using the DNA methyltransferase inhibitor (DNMTi) 5-aza-2\u2032-deoxycytidine (5-aza-dC) and the histone deacetylase inhibitor (HDACi) valproic acid (VPA). The HEKsst2 and PC3 cells were incubated with variable concentrations of 5-aza-dC and VPA to investigate the uptake of Lu-177-DOTATATE. Cell survival, subsequent to external X-rays (0.6 or 1.2 Gy) and a 24 h incubation with 57.5 or 136 kBq\/mL Lu-177-DOTATATE, was investigated via colony formation assay to examine the effect of the epidrugs. In the case of stimulated HEKsst2 cells, the uptake of Lu-177-DOTATATE increased by a factor of 28 in comparison to the unstimulated cells. Further, stimulated HEKsst2 cells demonstrated lower survival fractions (factor 4). The survival fractions of the PC3 cells remained almost unchanged. VPA and 5-aza-dC did not induce changes to the intrinsic radiosensitivity of the cells after X-ray irradiation. Clear stimulatory effects on HEKsst2 cells were demonstrated by increased cell uptake of the radioligand and enhanced SST2 receptor quantity. In conclusion, the investigated approach is suitable to stimulate the somatostatin receptor expression and thus the uptake of Lu-177-DOTATATE, enabling a more efficient treatment for patients with poor response to peptide radionuclide therapy (PRRT).<\/jats:p>","DOI":"10.3390\/cancers14102513","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T12:25:57Z","timestamp":1652963157000},"page":"2513","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy"],"prefix":"10.3390","volume":"14","author":[{"given":"Joerg","family":"Kotzerke","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Buesser","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Naumann","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswitha","family":"Runge","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Huebinger","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1320-6505","authenticated-orcid":false,"given":"Andrea","family":"Kliewer","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Drackendorfer Stra\u00dfe 1, D-07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Freudenberg","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brogsitter","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM198312223092506","article-title":"Somatostatin (second of two parts)","volume":"309","author":"Reichlin","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.chembiol.2006.08.012","article-title":"Design, synthesis, and biological evaluation of somatostatin-based radiopeptides","volume":"13","author":"Ginj","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3413\/Nukmed-0860-16-11","article-title":"Twins in spirit part IV-[(177)Lu] high affinity DOTATATE. A promising new tracer for peptide receptor radiotherapy?","volume":"56","author":"Brogsitter","year":"2017","journal-title":"Nuklearmedizin"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2967\/jnumed.115.165092","article-title":"Upregulation of Key Molecules for Targeted Imaging and Therapy","volume":"57","author":"Taelman","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.18632\/oncotarget.9462","article-title":"Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells","volume":"9","author":"Veenstra","year":"2018","journal-title":"Oncotarget"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1535-7163.MCT-13-0137","article-title":"Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2\u2032-deoxycytidine in solid tumor cells","volume":"12","author":"Venturelli","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4419-9967-2_13","article-title":"Epigenetic therapies in MDS and AML","volume":"754","author":"Griffiths","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1667\/RR3345","article-title":"Novel HDAC inhibitors with radiosensitizing properties","volume":"163","author":"Jung","year":"2005","journal-title":"Radiat. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-014-1713-x","article-title":"The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells","volume":"122","author":"Hosein","year":"2015","journal-title":"J. Neurooncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11154-020-09607-z","article-title":"Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer","volume":"22","author":"Klomp","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/wjnm.WJNM_120_20","article-title":"Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option","volume":"20","author":"Mileva","year":"2021","journal-title":"World J. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Shah, R.G., Merlin, M.A., Adant, S., Zine-Eddine, F., Beauregard, J.-M., and Shah, G.M. (2021). Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of 177Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells. Cancers, 13, Available online: https:\/\/www.mdpi.com\/2072-6694\/13\/2\/232.","DOI":"10.3390\/cancers13020232"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00259-019-04499-x","article-title":"Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours","volume":"47","author":"Adant","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40644-018-0136-x","article-title":"Changes in biodistribution on (68)Ga-DOTA-Octreotate PET\/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression","volume":"18","author":"Cherk","year":"2018","journal-title":"Cancer Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1210\/endo.138.10.5571","article-title":"Iodide Uptake and Experimental 131I Therapy in Transplanted Undifferentiated Thyroid Cancer Cells Expressing the Na+\/I\u2212 Symporter Gene","volume":"138","author":"Shimura","year":"1997","journal-title":"Endocrinology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2001-11010","article-title":"Gene therapy with sodium\/iodide symporter in hepatocarcinoma","volume":"109","author":"Haberkorn","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.gt.3301943","article-title":"Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose","volume":"10","author":"Haberkorn","year":"2003","journal-title":"Gene Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1476-5381.2009.00412.x","article-title":"Visualization of gene expression in the live subject using the Na\/I symporter as a reporter gene: Applications in biotherapy","volume":"159","author":"Baril","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1073\/pnas.89.23.11151","article-title":"Molecular cloning and functional expression of a brain-specific somatostatin receptor","volume":"89","author":"Bruno","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","first-page":"939","article-title":"Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28","volume":"42","author":"Lolait","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1073\/pnas.90.9.4196","article-title":"Cloning and characterization of a fourth human somatostatin receptor","volume":"90","author":"Rohrer","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.7150\/thno.24017","article-title":"Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions","volume":"8","author":"Heidari","year":"2018","journal-title":"Theranostics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.110.079004","article-title":"Imaging expression of the human somatostatin receptor subtype-2 reporter gene with 68Ga-DOTATOC","volume":"52","author":"Zhang","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kliewer, A., Mann, A., Petrich, A., Poll, F., and Schulz, S. (2012). A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039458"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1210\/me.2012-1329","article-title":"Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor","volume":"27","author":"Petrich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/me.2009-0315","article-title":"Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation","volume":"24","author":"Poll","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"36529","DOI":"10.1074\/jbc.M503111200","article-title":"RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo","volume":"280","author":"Pulukuri","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"062503","DOI":"10.1118\/1.4876296","article-title":"On the dose calculation at the cellular level and its implications for the RBE of (99m)Tc and (1)(2)(3)I","volume":"41","author":"Freudenberg","year":"2014","journal-title":"Med. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/09553002.2016.1168533","article-title":"Comparison of the radiotoxicity of the (99m)Tc-labeled compounds (99m)Tc-pertechnetate, (99m)Tc-HMPAO and (99m)Tc-MIBI","volume":"92","author":"Maucksch","year":"2016","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Klomp, M.J., Dalm, S.U., van Koetsveld, P.M., Dogan, F., de Jong, M., and Hofland, L.J. (2021). Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [(111)In]In-DOTATATE Uptake in NET Cells. Cancers, 13.","DOI":"10.3390\/cancers13194905"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Dasgupta, P., G\u0171nther, T., and Schulz, S. (2021). Pharmacological Characterization of Veldoreotide as a Somatostatin Receptor 4 Agonist. Life, 11.","DOI":"10.3390\/life11101075"},{"key":"ref_34","first-page":"151","article-title":"Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells","volume":"20","author":"Liu","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41419-018-0487-z","article-title":"Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells","volume":"9","author":"Gailhouste","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.ymthe.2018.04.018","article-title":"Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells","volume":"26","author":"Gailhouste","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/en.2007-1525","article-title":"Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications","volume":"149","author":"Torrisani","year":"2008","journal-title":"Endocrinology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/acs.molpharmaceut.9b00512","article-title":"Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma","volume":"16","author":"Li","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-1119(02)00397-9","article-title":"Upregulation of prostate specific membrane antigen\/folate hydrolase transcription by an enhancer","volume":"285","author":"Noss","year":"2002","journal-title":"Gene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4143\/crt.2014.026","article-title":"In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation","volume":"47","author":"Chie","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2967\/jnumed.118.224048","article-title":"Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro","volume":"60","author":"Jin","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_42","first-page":"1113","article-title":"Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials","volume":"11","author":"Silver","year":"2020","journal-title":"Front. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.21.00703","article-title":"Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium","volume":"39","author":"DuBois","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s13277-013-0796-x","article-title":"Imaging and therapy of hSSTR2-transfected tumors using radiolabeled somatostatin analogs","volume":"34","author":"Wang","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_45","first-page":"917968","article-title":"Somatostatin receptor based imaging and radionuclide therapy","volume":"2015","author":"Xu","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nucmedbio.2010.05.007","article-title":"Treatment of transplanted tumor of lung adenocarcinoma A549 transfected by human somatostatin receptor subtype 2 (hsstr2) gene with 188Re-RC-160","volume":"37","author":"Zhao","year":"2010","journal-title":"Nucl. Med. Biol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/10\/2513\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:06Z","timestamp":1760138106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/10\/2513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["cancers14102513"],"URL":"https:\/\/doi.org\/10.3390\/cancers14102513","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}